Toft Group Executive Search Named in the Top 50 Recruiters in the Americas

June 4, 2018, San Diego, CA:  Toft Group, a global life sciences and healthcare executive recruiting firm, today announced it has been named one of the Top 50 Recruiters in the Americas by Hunt Scanlon Media, the most widely referenced global news source in the human capital sector. Hunt Scanlon recently presented its annual roundup of the largest, fastest-growing executive search firms in the Americas. These are the 50 top firms in this dynamic marketplace – ranging from the largest recruiting and talent leadership solutions firms to the leading boutique specialists.

The complete list of search firms was published in the Recruiters Rankingsspecial issue of the Hunt Scanlon Executive Search Review.

“Toft Group is honored to be recognized among the top recruiters,” commented Robin Toft, President & CEO of Toft Group. “As today’s talent gap has become a hiring crisis, the need for experienced and talented executive search professionals has grown. Our success comes from our team of highly experienced search consultants, our commitment to delivering exceptional results and our collaborative network of partners, clients, and candidates who share a passion for healthcare advancements and innovation.”

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston. For more information, visit www.thetoftgroup.com.

About Hunt Scanlon Media

Hunt Scanlon Media has been informing the senior talent management sector for over 25 years. Their global news and intelligence data comes in many forms, including daily newswires, talent leadership reports, newsletter briefings and social media alerts. The privately-held company is headquartered in Greenwich, Conn.

 

Toft Group Completes Search for Vice President, Clinical Affairs for Kiyatec, Inc. in Greenville, SC

Executive search firm Toft Group has placed Charlene Knape as Vice President, Clinical Affairs for Kiyatec, Inc. in Greenville, SC.

Ms. Knape is a clinical operations executive with many years of industry experience, primarily within diagnostics and medical devices. She recently served as Senior Director, Clinical Development for Inivata, a privately-held company developing liquid biopsy assays analyzing cancer genomics. Prior to this, Ms. Knape worked for Becton Dickinson in their Diagnostic BioSpecimen Solutions group. In this role, she was responsible for sourcing rare samples including TB+ sputum, breast cancer, and cervical cancer from local sources and developing countries to support internal R&D development programs. Previously, Ms. Knape worked with Micell Technologies, LabCorp, EndoTex Interventional Systems, Avocet Medical and Somnus Medical Technologies. Ms. Knape holds an M.T. degree in medical laboratory sciences from Michener Applied Health Sciences in Toronto.

About Kiyatec, Inc.

Kiyatec, Inc. offers cell-based Drug Response Profiling (DRP) services to help pharmaceutical and biotech companies accelerate the development of their small molecule compounds and biologic drugs. Their scientific team routinely performs advanced three-dimensional (3D) cell-based assays using immortalized cell lines, patient-derived xenograft (PDX) tissues or clinically sourced primary cancer tissues, including rare tumors, to better predict in vivo response.  Their 3D tumor models are being used to identify in vitro drug response across a broad array of therapeutic classes and biological targets.

Toft Group Completes Search for Chief Financial Officer for Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) in Los Angeles, CA

Executive search firm Toft Group has placed John W. Beck as Chief Financial Officer at Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) in Los Angeles, CA. Ritter Pharmaceuticals is a developer of novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases with an initial focus on the development of RP-G28, a drug candidate with the potential to be the first FDA-approved treatment for lactose intolerance.

Mr. Beck joins Ritter Pharmaceuticals with over 25 years of experience in leadership roles across finance, accounting and compliance, capital markets, fundraising, mergers and acquisitions and commercial operations in life sciences and high technologies companies. Mr. Beck was previously CEO of both Wellspring Water Technologies of West Tech Medical, companies he co-founded. Prior to that, Mr. Beck was CFO for Ardea Biosciences. Before joining Ardea, Mr. Beck spent 10 years with Metabasis Therapeutics as a co-founder and CFO. Mr. Beck has also served as finance director at Neurocrine Biosciences. Mr. Beck currently serves on the boards of advisors for August Therapeutics and Pinnacle Medical Holdings.

Robin Toft, President and CEO of Toft Group, said, “Mr. Beck’s significant experience in public company management, his relationships within the investor community and his background in licensing and mergers and acquisitions will serve an important function for Ritter Pharmaceuticals as it moves into phase 3 clinical development with RP-G28 and prepares to commercialize this important asset, either alone or with partners, and build value for investors.”

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. The company’s lead product candidate, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions of people worldwide. RP-G28 has been studied in Phase 2 trials, and is expected to commence Phase 3 clinical development in the second quarter of 2018. Ritter Pharmaceuticals, Inc. is further exploring the therapeutic potential that gut microbiome changes may have on treating/preventing a variety of diseases including gastrointestinal diseases, cancer, metabolic, and liver disease.

Toft Group Hiring: Managing Director, San Francisco

Toft Group is Hiring: Managing Director, San Francisco

Toft Group Executive Search is looking for a Managing Director to work in our San Francisco office. The Managing Director (MD) will report directly to the Chief Operating Officer who manages our San Francisco base of operations. The MD will be responsible for creating and fostering new customer relationships with life science and healthcare high tech customers within northern California, with a focus on the San Francisco bay area, by leveraging the Toft Group’s existing, highly successful executive search services brand and highly differentiated delivery model.

The focus of the role is to generate new customers and executive search revenue for the company.  The MD will independently create a unique business development strategy for the target market to secure new accounts and foster/grow business from existing customer within northern California, and opportunistically nationwide.

The MD will give customer presentations, secure search assignments, lead search assignments (in partnership with an experienced recruiter on each assignment), and delegate assignments she/he wins that are not within her/his area of expertise to the appropriate Toft Group team.  S/he will strengthen the company’s retained search service, and fill the role of trusted valued partner to s valued customer.

Managing Directors at Toft Group are responsible for originating, executing and nurturing an ongoing book of business in line with the corporate business plan and personal target performance goals. They are responsible for bringing in new local searches and leading those that are aligned with their expertise, while assigning others to the most qualified search teams within Toft Group.

Market Development:

  • Develop and execute a market strategy for increasing revenue and market share within northern California, resulting in securing new customers and searches.
  • Develop appropriate marketing tactics for the region, in conjunction with the Marketing Director.
  • Regularly communicate and build relationships with Toft Group consultants to leverage relationships, share ideas, leads and market intelligence; this may also include giving presentations to colleagues.
  • Acquire and continually build on an in-depth knowledge of the industry sectors, companies, and products.
  • Map relevant markets and keeping abreast of any changes affecting the marketplace including organization/management changes and capitalizing on any arising opportunities.
  • Establish and increase market profile e.g.: compiling, distributing and leveraging from market information, organizing events, attending networking events, maintaining relationships with previously placed candidates and hiring managers.
  • Serve as customer account manager, maintaining relationship and communications with customers.

Position Requirements & Experience:

  • Degree in Life Sciences or Business/Marketing required; advanced degree preferred.
  • Minimum 5+ years of prior sales or business development experience, ideally in within Life Science and Healthcare High Tech executive search firm.
  • Superior consultative negotiation skills, with proven success in selling professional services to sophisticated C-level customers.
  • Track record of strong revenue generation – the personal goal will be generating service to new accounts within a teamwork model.
  • Strong & established network of executive level relationships within Life Science and Healthcare High Tech companies.
  • Successful track record of building and maintaining solid relationships with customers and peers within the industry.
  • Proven track record of developing and implementing a business development plan that achieves sustainable results.
  • Exceptional relationship management skills and the ability to build and grow connections with people of all types and backgrounds.
  • Understanding of industry trends and market conditions.
  • Industry content knowledge, ideally including pharmaceutical drug development and regulatory approval process a strong plus.

Email for more information on this position
or submit your resume

Robin Toft on BISTalk Radio’s “Women of Impact” Series- available as podcast!

Robin Toft was recently interviewed on ESPN 1700 radio. The podcast version of this interview is available now on BISTalk Radio’s “Women of Impact” series. Hear about Robin’s inspiring business path, why only doing “what you do best” might not be the ultimate route to success, and what you can do to attract the next wave of talent to your company.

PODCAST

FACEBOOK LIVE VIDEO

Toft Group Completes Executive Search for Synthetic Genomics Inc. in La Jolla, CA

Executive search firm Toft Group has placed Dr. Rachel Cervantes as Vice President of Business Development at Synthetic Genomics Inc., in La Jolla, CA. Dr. Cervantes was previously Vice President of Corporate Development at the University City Science Center in Philadelphia. She has over 20 years of experience in the commercial and scientific aspects of pharmaceutical innovation within large pharmaceutical, biotech, and academic research environments. She was Senior Director of Business Development at Egalet Corporation, and held similar roles at Inovio Pharmaceuticals and Merck & Co., where, in addition to evaluating, structuring and negotiating global healthcare partnerships, she also held leadership roles within R&D and marketing. In addition to her private sector experience, Dr. Cervantes was a research associate at the Salk Institute at Biological Sciences where she conducted NIH-funded cancer research. She holds a PhD in Cell & Molecular Biology from the University of Cincinnati, and an MBA from the University of Pennsylvania.

About Synthetic Genomics Inc.

Synthetic Genomics Inc. (SGI) is a global leader in the fields of synthetic biology and synthetic genomics utilizing our foundational intellectual property in these rapidly evolving disciplines to design and build biological systems to solve global sustainability challenges. SGI provides solutions in genomics research, bioproduction, and applied products. Their research segment is focused on genomics solutions for academic and commercial R&D organizations. The commercial products and services include instrumentation, reagents, DNA synthesis services, and bioinformatics services and software. SGI’s efforts in bio-based production are targeted at improving existing biological production hosts and developing entirely new synthetic production hosts with the goal of more efficient production of pharmaceuticals, vaccines, nutritionals, and bio-industrial products derived from renewable biological resources. Their host systems can also enable entirely new products that were once not scientifically or economically viable.

Toft Group Completes Search for Vice President, Sales & Business Development for Northway Biotech, Inc. in San Francisco, CA

Executive search firm Toft Group has placed Laura King as Vice President, Sales and Business Development for Northway Biotech in San Francisco, CA.

Ms. King has over 20 years in business development within the biotech industry. She previously served as Senior Director for CMC Biologics, and Business Development Manager for Cook Pharmica. She has also worked in business development with Novozymes, Catalent Pharma Solutions and JRH Biosciences. Ms. King holds a bachelor of science in psychology/neuroscience from Northeastern University.

About Northway Biotech

Northway Biotech is a startup affiliate of Biotechpharma, a contract development and manufacturing organization (CDMO), supporting clients world-wide. Biotechpharma performs different projects at any stage, starting from cell line construction and process development up to cGMP production of biopharmaceutical products.

Toft Group Appoints Dani Gavson as Vice President

Team expansion driven by ongoing talent-gap crisis, which has accelerated demand for top healthcare executives

Toft Group Executive Search, a global life sciences and healthcare high-tech executive recruiting firm with offices in San Francisco, San Diego and Boston, today announced Dani Gavson has joined Toft Group as vice president.

“Toft Group is expanding to meet customers’ increasing calls for highly qualified, diverse executive candidates working at the intersection of biotech and high-tech,” said Robin Toft, founder, president and chief executive officer of Toft Group. “As today’s talent gap becomes a hiring crisis, the need for experienced and talented executive search professionals has grown. We are excited that Dani has joined Toft Group to help fill that need, since she has a strong track record of placing hard to hire executives.”

Ms. Gavson joins Toft Group with more than 25 years as an executive search consultant specializing in life sciences. She has worked with executive search firms both in South Africa and the United States, and owned her own San Diego-based firm. Ms. Gavson has placed exceptional and highly sought-after industry experts in all phases of the drug development life cycle – including translational research, clinical research and development, and medical affairs in many of the world’s leading companies in North America and globally. She also has many years of expertise in identifying highly skilled physicians and physician scientists for executive roles in the pharmaceutical and biotech sector.

Ms. Gavson obtained her bachelor’s degree in commerce from the University of the Witwatersrand, Johannesburg.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Completes Search for Chief Medical Officer and Senior Vice-President of Medical Affairs for Natera, Inc. (NASDAQ: NTRA), in San Carlos, CA

Executive search firm Toft Group has placed Paul R. Billings, M.D, Ph.D., as Chief Medical Officer and Senior Vice-President of Medical Affairs at Natera, Inc. in San Carlos, CA.

Dr. Billings is a leading authority on genomics and diagnostics in medical practice and he will help lead Natera’s efforts across reproductive health, oncology, and new emerging businesses. Natera is a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA (cfDNA).

“Paul is a highly experienced medical affairs leader, with the ability to drive growth and awareness for diagnostic tests and services. We anticipate he will add great value to the Natera team as they introduce new products and services to the market” said Robin Toft, CEO of Toft Group Executive Search.

Dr. Billings is a board-certified internist and clinical geneticist with more than 30 years of experience in genomics and molecular medicine. He is the author of nearly 200 publications on genomic medicine and has held academic and research appointments at Harvard University, UC San Francisco, Stanford University, and UC Berkeley. Prior to joining Natera, Dr. Billings was Chief Medical Officer of Life Technologies, Inc., and consulting CMO of the Genetic Sciences Division of Thermo Fisher Scientific. He previously was SVP and Senior Physician at Laboratory Corporation of America Holdings. He has served on the Scientific Advisory Board of the Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the HHS Secretary’s Advisory Committee on Genomics, Health and Society. His work formed the basis of the Genetic Information Nondiscrimination Act of 2008 (GINA).

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Natera

Natera is a global leader in cell-free DNA testing. The mission of the company is to transform the diagnosis and management of genetic diseases. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform.